Cassava Sciences | PTIE - Debt

Stock Price
1.90
Daily Change
-0.05 -2.56%
Monthly
-10.38%
Yearly
-18.80%
Q1 Forecast
1.93

Cassava Sciences reported $0 in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Amgen USD 54.59B 1.62B Sep/2025
Biogen USD 6.29B 309.5M Sep/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 187.52B 31.58B Mar/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Geron USD 121.84M 3.12M Jun/2025
J&J USD 45.8B 4.97B Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025